Form 8-K · Current Report · Filed 2025-07-18
Hologic, Inc. Refinances Term Loan and Revolving Credit Facility
On July 15, 2025, Hologic, Inc. refinanced its term loan and revolving credit facility by entering into Refinancing Amendment No. 4 to its Amended and Restated Credit and Guaranty Agreement. The refinancing resulted in a $1.169 billion secured term loan with a maturity date of July 15, 2030, and a $1.250 billion secured revolving credit facility with a maturity date of July 15, 2030. The refinancing provides additional flexibility for the Company and its subsidiaries under certain covenants. All defined terms used in this Current Report on Form 8-K that are not otherwise defined herein have the meanings ascribed to such terms in the Amended Credit Agreement.
- Filer
- Hologic Inc. HOLX · NASDAQ
- Filed
- Accession
- 0001193125-25-160850
- CIK
- 0000859737
- Signal
- Medium impactHealthcare
- Source
- Official filing on sec.gov ↗
Items reported
Entry into a Material Definitive Agreement
Creation of a Direct Financial Obligation
Financial Statements and Exhibits
Market reaction
Close before filing
$64.02
Next session
-0.5%
Since filing
+18.7%
Latest close
$76.01
What happened, not what will happen — closing prices around the filing date.
Precedent
Previous filings from HOLX reporting the same item, with the next session's move:
Exhibits (1)
About Hologic Inc.
Hologic Inc. is a leading global medical technology company focused on improving women's health and well-being. Its primary function is to develop, manufacture, and supply diagnostic products, medical imaging systems, and surgical products, which play crucial roles in the prevention and treatment of diseases. Hologic's key sectors include breast health, diagnostics, gynecological surgical, and skeletal health solutions. It is renowned for innovative technologies such as 3D mammography or tomosynthesis, which are significant advancements in breast cancer detection. With a commitment to enhancing healthcare quality and efficiency, Hologic operates across a diverse range of healthcare settings, from hospitals and clinics to laboratories and research facilities. Headquartered in Marlborough, Massachusetts, Hologic has established itself as a pivotal player in women's health diagnostics, contributing to its substantial market presence and influence in the global healthcare sector.
Never miss another HOLX filing
Profitelligence watches EDGAR around the clock and alerts you within seconds.